Skip to main content

GW Medical Student Research Day

Tisagenlecleucel for Treatment of Relapsed B-ALL in a Patient with CHEK2 Mutation and Papillary Thyroid Carcinoma

Abraham Ipe, George Washington University
Anne Angiolillo, George Washington University
Melissa Wills, Children’s National Hospital
Erica Wyche, Children’s National Hospital
David Jacobsohn, George Washington University
Jinjun Cheng, Children’s National Hospital
Miriam Bornhorst, George Washington University
Joyce Turner, George Washington University
Anant Vatsayan, George Washington University

Document Type

Poster

Keywords

CHEK2 Mutation; Tisagenlecleucel; Papillary Thyroid Carcinoma

Publication Date

Spring 2022

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Open Access

1

Comments

Poster presented at GW Medical Student Research Day 2022.

Included in

Medicine and Health Sciences Commons

COinS

Tisagenlecleucel for Treatment of Relapsed B-ALL in a Patient with CHEK2 Mutation and Papillary Thyroid Carcinoma